Komori
Otsuka Holdings (4578) · TargetAdvanced

Building the Three Core Brands into ¥100 Billion Brands and Developing the Three Growth Brands

First written in FY2021. 11 of 12 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026-H1.

12entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q2 – FY2026-H12022: 320222023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Developing Strong Product Categories and Creating Health-Related BusinessesA theme 19 companies write about · 0 as a headwind · 20 as a tailwind

8 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「Revenue also increased in the nutraceutical-related business, as all 3 categories based on social issues designated as growth drivers achieved growth.」

    All 3 social-issue categories grew. Revenue was ¥105,387 million for For Climate & Environmental Risk, ¥31,822 million for For Women's Health and ¥127,063 million for For Healthier Life.
  2. FY2024AdvancedAnnual report

    「In the nutraceuticals-related business, revenue increased as all three newly established categories based on social issues, positioned as growth drivers, grew, led by Pocari Sweat and Nature Made.」

    The previous goals of building the core brands into ¥100 billion brands and developing the growth brands have evolved into growth across all 3 social-issue categories and business revenue of ¥557,043 million.
  3. FY2024-H1AdvancedAnnual report

    「Revenue in the nutraceuticals-related business increased, as all categories grew, led by Pocari Sweat and Nature Made, across the three new categories organized by social issue and designated as growth drivers.」

    The core brands were reorganized into 3 categories based on social issues, and all categories—For Climate & Environmental Risk, For Women’s Health and For Healthier Life—grew. Revenue from the nutraceuticals business totaled ¥271,826 million, up 20.2% year on year.
  4. FY2024-Q1AdvancedAnnual report

    「Combined revenue from the three brands that the Group classifies as core brands—Pocari Sweat, Nature Made and Nutrition et Santé brands—was ¥83.414 billion, up 21.4% year on year. Combined revenue from the three brands classified as development brands—Deya Foods brands, Equelle and Bodymainte—was ¥8.068 billion, up 19.3% year on year.」

    Revenue from both the 3 core brands and the 3 growth brands increased, demonstrating progress toward building the 3 core brands into ¥100 billion brands and developing the 3 growth brands.
  5. FY2023AdvancedAnnual report

    「Combined revenue from the three brands that the Group classifies as core brands—Pocari Sweat, Nature Made and Nutrition et Santé brands—was ¥312.998 billion, up 14.8% year on year. Combined revenue from the three brands classified as development brands—Deya Foods brands, Equelle and Bodymainte—was ¥27.851 billion, down 2.3% year on year.」

    Revenue from the 3 core brands rose to ¥312,998 million, demonstrating progress toward building them into ¥100 billion brands. Meanwhile, revenue from the 3 growth brands declined.
  6. FY2023-Q3AdvancedAnnual report

    「Combined revenue from the three brands that the Group classifies as core brands—Pocari Sweat, Nature Made and Nutrition et Santé brands—was ¥234.607 billion, up 15.7% year on year. Combined revenue from the three brands classified as development brands—Deya Foods brands, Equelle and Bodymainte—was ¥20.621 billion, down 2.6% year on year.」

    Revenue from the 3 core brands totaled ¥234,607 million, up 15.7% year on year, demonstrating sales growth toward building them into ¥100 billion brands. Meanwhile, revenue from the 3 growth brands declined 2.6%.
  7. FY2023-Q2AdvancedAnnual report

    「Combined revenue from the three brands that the Group classifies as core brands—Pocari Sweat, Nature Made and Nutrition et Santé brands—was ¥147.517 billion, up 15.5% year on year. Combined revenue from the three brands classified as development brands—Deya Foods brands, Equelle and Bodymainte—was ¥13.528 billion, down 4.4% year on year.」

    Revenue from the 3 core brands rose 15.5% year on year, demonstrating sales growth toward building them into ¥100 billion brands. Meanwhile, revenue from the 3 growth brands declined 4.4% year on year.
  8. FY2023-Q1AdvancedAnnual report

    「Combined revenue from the three brands that the Group classifies as core brands—Pocari Sweat, Nature Made and Nutrition et Santé brands—was ¥68.695 billion, up 23.4% year on year. Combined revenue from the three brands classified as development brands—Deya Foods brands, Equelle and Bodymainte—was ¥6.760 billion, down 4.4% year on year.」

    Revenue from the 3 core brands rose 23.4% year on year, demonstrating sales growth toward building them into ¥100 billion brands. Meanwhile, revenue from the 3 growth brands declined 4.4%.
  9. FY2022AdvancedAnnual report

    「Revenue from the 3 brands designated by the Group as its core brands, Pocari Sweat, Nature Made and the brands of Nutrition & Santé, totaled ¥272,642 million, up 17.9% year on year. Revenue from the 3 brands designated as growth brands, the brands of Daiya Foods, Equelle and BODY MAINTÉ, totaled ¥28,514 million, up 5.3%.」

    Revenue from the 3 core brands totaled ¥272,642 million, while revenue from the 3 growth brands totaled ¥28,514 million, demonstrating progress toward building the 3 core brands into ¥100 billion brands and developing the 3 growth brands.
  10. FY2022-Q3AdvancedAnnual report

    「Combined revenue from the three brands that the Group classifies as core brands—Pocari Sweat, Nature Made and Nutrition et Santé brands—was ¥202.816 billion, up 17.5% year on year. Combined revenue from the three brands classified as development brands—Deya Foods brands, Equelle and Bodymainte—was ¥21.160 billion, up 3.8% year on year.」

    Revenue from the 3 core brands totaled ¥202,816 million, up 17.5% year on year, demonstrating progress toward building them into ¥100 billion brands. Revenue from the 3 growth brands also rose 3.8% year on year.
  11. FY2022-Q2AdvancedAnnual report

    「Revenue from the 3 brands designated by the Group as its core brands, Pocari Sweat, Nature Made and the brands of Nutrition & Santé, totaled ¥127,741 million, up 18.7% year on year. Revenue from the 3 brands designated as growth brands, the brands of Daiya Foods, Equelle and BODY MAINTÉ, totaled ¥14,145 million, up 3.7% year on year.」

    Revenue from the 3 core brands totaled ¥127,741 million, up 18.7% year on year, while revenue from the 3 growth brands rose 3.7% to ¥14,145 million, demonstrating progress toward building the 3 core brands into ¥100 billion brands and developing the 3 growth brands.
  12. FY2021First statedAnnual report

    「The company is working to build a foundation for developing its 3 core brands into ¥100 billion brands and its 3 growth brands into brands that will support the business in the future.」

    The company has stated for the first time its goal of developing its 3 core brands into ¥100 billion brands and its 3 growth brands into brands that will support the business in the future. Measures include expansion into new categories and regions and optimization of its brand strategy.
Moved together

"Pipeline Progress in Clinical Development, Regulatory Approval and Commercialization" moved the same way as this thread, in the same document, in 11 of its 12 moves.

1111101088★123456
  1. ★This thread
  2. 1Pipeline Progress in Clinical Development, Regulatory Approval and Commercialization11×
  3. 2Investment Plan for Research and Production Facilities11×
  4. 3Continued investment in research and development10×
  5. 4Expansion of Overseas Sales of Pharmaceutical and Health-Related Products10×
  6. 5Sustainable growth driven by 3 global products and 3 next-generation products8×
  7. 6Improving the Earnings Structure of the Consumer-Related Business8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Otsuka Holdings's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Building the Three Core Brands into ¥100 Billion Brands and Developing the Three Growth Brands | Otsuka Holdings Co.,Ltd. (4578) | Komori